Keyphrases
COVID-19
66%
COVID-19 Pandemic
37%
Severe COVID-19
23%
Drug-gene Interaction
23%
Dutch
22%
Depressive Symptoms
18%
Well-being
18%
Pharmacist
18%
Drug Interactions
18%
TMPRSS2 Gene
18%
Citalopram
18%
Positive Check
18%
Genetic Contribution
18%
Genetic Model
18%
Homeworkers
18%
Genetic Architecture
18%
Polymerase Chain Reaction
18%
Negative Test
18%
Anxiety Symptoms
18%
Pharmacogenetic Testing
18%
Case Prediction
18%
Quality of Life
18%
COVID-19 Susceptibility
18%
Human Genetics
18%
Hospital Care
18%
Health Practitioners
18%
Patient-physician
18%
Practical Barriers
18%
Clinical Model
18%
Virus
18%
Coronavirus Disease (COVID)
18%
SARS-CoV-2 Testing
18%
Polymerase Chain Reaction Assay
15%
CYP2C19
14%
SARS-CoV-2 Infection
14%
Mental Health
14%
COVID-19 Severity
13%
Population Biobanks
9%
Genetic Predisposition
9%
Proportions of Variance
9%
Information Composition
9%
Non-home
9%
Genetic Variation
9%
Shared Environment
9%
Physical Health
9%
Nurture
9%
Genetic Data
9%
Heritability
9%
Biobank Participants
9%
Relative Contribution
9%
Biochemistry, Genetics and Molecular Biology
Genetics
91%
SARS Coronavirus
66%
Pharmacogenetics
56%
Genetic Divergence
42%
Genetic Architecture
37%
Genetic Determinism
28%
Genome Wide Association Study
25%
Single Nucleotide Polymorphism
18%
Decision Support System
18%
TMPRSS2
18%
Genetic Susceptibility
18%
Angiotensin-Converting Enzyme 2
18%
Whole Genome Sequencing
18%
Human Genetics
18%
Population Dynamics
18%
Genetic Association
18%
Wellbeing
18%
Coronavirinae
18%
Genetic Variation
17%
Gene Expression
15%
Mendelian Randomization
14%
Tumor Necrosis Factor Alpha
12%
Tumor Necrosis Factor
12%
Leukocyte
9%
FUT2
9%
MUC1
9%
Transcriptome
9%
Flippase
9%
Myeloid
9%
BCL11A
9%
Single-Nucleotide Polymorphism
9%
Interferon
9%
interferon
9%
Blood Coagulation Factor
9%
Mucin
9%
Virus Replication
9%
Cell Adhesion Molecule
9%
Disseminated Intravascular Coagulation
9%
Immunogenicity
8%
Genetic Predisposition
7%
Drug Efficacy
6%
Attitude
6%
Drug Safety
6%
Drug Response
6%
Medicine and Dentistry
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
44%
Cohort Analysis
30%
Quality of Life
23%
Gene Interaction
23%
Infection
21%
Symptom
20%
Outpatient
18%
Wellbeing
18%
Polymerase Chain Reaction
18%
Healthcare Practitioner
18%
Drug Interaction
18%
Citalopram
18%
Pharmacogenetic Testing
18%
Hospital Care
18%
Gender and Sex
18%
Medicine
18%
CYP2C19
14%
Mental Health
7%
Drug Dose Reduction
7%
CYP3A4
7%
Medical Research
6%
Multiple Choice Test
6%
Protective Factor
6%
Health Care
5%
Logistic Regression Analysis
5%
